Stay current with insights from our analysts and industry updates. We also offer customised newsletters to keep your management, sales and marketing teams fully informed - contact us to find out more.
Stay current with insights from our analysts and industry updates. We also offer customised newsletters to keep your management, sales and marketing teams fully informed - contact us to find out more.
20-Apr-16 India's healthcare sector is poised to grow to USD280 bn by 2020, is expected to be a leader in e-health by 2019. It should reach USD160 bn by 2017, accounting for 4.2% of GDP. Indian telemedicine is showing robust growth at approximately 20% and is projected to grow from USD8 mn in 2012 to USD19 mn by 2017. [image: Money Control]
Read More
20-Apr-16 Singapore’s medical devices industry is aiming to hit SGD5 bn in manufacturing output. The government is targeting up to 1 mn foreign patients a year, which will contribute SGD2.6 bn (USD1.6 bn), or about 1%, to Singapore’s GDP. Already there are 30 global medical technology companies, including the industry’s leading manufacturers, with operations and R&D in Singapore. [image: Asian Briefing].
Read More
19-Apr-16 Walgreens Boots Alliance has bought a 15% stake in Russian pharmacy chain 36,6. In return Walgreens Boots Alliance has sold its Russian distributor Alliance Healthcare Russia to 36,6. The country’s commercial drug market can be very promising for foreign investors. [image: Newseurope]
Read More
19-Apr-16 Scripps Health will work with a Mexican health insurer to create the region's first hospital aimed to meet the needs of the growing number of Southern Californians who seek medical care south of the border. [image: Scripps Health]
Read More
19-Apr-16 The Indian Ministry of Health and Family Welfare has issued draft rules that establish registration and quality system requirements for medical devices and IVDs distinct from pharmaceutical products. Although the new rules pertain only to manufacturers based in India, they are significant by showing that the government now distinguishes medical devices as a separate industry from pharmaceuticals. [image: Business Today]
Read MoreGGM is a research and advisory firm helping clients grow profitably in international markets.
We believe the only way to understand a market properly is on the ground. Intelligence from our in-country consultants gives you a competitive advantage in China, Asia, Latin America, the Middle East, Africa and other opportunity areas.
Our clients benefit from accurate data, reliable insights and strategic advice, giving them the confidence to make better business decisions and succeed in their global growth markets.
Successful track record in your sector since 1992
In-country research consultants in over 40 markets
Value for money - quality results at affordable rates
Work led by senior directors with >20 years experience
Proven frameworks for data analysis and strategy
Pragmatic advice based on accurate data and reliable insights
Find out more about our international market intelligence and strategy services
Get in touch to discuss your growth markets research and advisory needs:
Email: info@ggmkts.com